Defence Therapeutics to present ADC advances at 17th World ADC San Diego

Oct 1, 2026 03:39 (24d ago)

Verifying

Defence Therapeutics announced participation in the 17th World ADC San Diego conference.
CEO Dr. Amie Phinney will discuss intracellular delivery advances for antibody-drug conjugates.
Defence Therapeutics will showcase its proprietary offering at the conference.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.